- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06726499
Orthokeratology Lens Decentration with Two Designs of Corneal Refractive Therapy™ Lenses: a One-year Prospective Study
December 9, 2024 updated by: Gonzalo Carracedo, Universidad Complutense de Madrid
Background/Objectives: To examine the trend of treatment zone (TZ) decentration over 12 months of Orthokeratology (OK) wear using two corneal refractive therapy (CRT) lens designs: standard (STD) and dual axis (DA).
Methods: A prospective, randomized, longitudinal study was conducted at the Optometry Clinic of the Complutense University of Madrid.
Subjects were fitted with STD or DA designs in one of the eyes, randomly.
Refraction, uncorrected visual acuity (VA) and corneal topography were performed at baseline, 1-night, 1-week, 1-, 3-, 6- and 12-month of lens wear.
Subjects requiring lens parameter adjustments or replacements after 3 months were excluded.
Decentration was measured by subtracting pre-OK from post-OK tangential curvature maps at each visit, with decentration distance and corneal optical TZ measured using MATLAB.
Correlations between decentration and visual acuity (VA) were also analyzed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28032
- University Complutense of Madrid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age between 8 to 17 years old
- Myopia up -6.00 D
Exclusion Criteria:
- Ocular diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: spherical design
|
Contact lens for myopia progression
|
|
Experimental: Toric Design
|
Contact lens for myopia progression
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
contact lens centration
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2018
Primary Completion (Actual)
June 15, 2018
Study Completion (Actual)
June 12, 2024
Study Registration Dates
First Submitted
December 5, 2024
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Estimated)
December 10, 2024
Study Record Updates
Last Update Posted (Estimated)
December 10, 2024
Last Update Submitted That Met QC Criteria
December 9, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16/371-E
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia Progression
-
Aston UniversityRecruitingMyopia ProgressionNew Zealand
-
Indizen Optical Technologies, S.L.U.University of Minho; University of Ulster; Hospital San Carlos, MadridNot yet recruitingMyopia ProgressionSpain, Portugal, United Kingdom
-
Benha UniversityCompletedMyopia ProgressionEgypt
-
SightGlass Vision, Inc.Recruiting
-
Essilor InternationalRecruiting
-
IDB VisionCare SDN BHDSingapore National Eye CentreRecruiting
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Oupushifang Pharmaceutical Technology Co., Ltd.Seefunge Pharmaceutical Technology Co., Ltd.; AUTEK China Inc.Recruiting
-
Central Hospital, Nancy, FranceCompleted
Clinical Trials on Spherical CRT
-
Johnson & Johnson Vision Care, Inc.Completed
-
University of Sao Paulo General HospitalMerit Medical Systems, Inc.RecruitingHemophilia | Arthropathy | Synovitis | Hemarthrosis | Embolization | Clotting Factor DeficiencyBrazil
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bausch & Lomb IncorporatedCompleted
-
University of VirginiaJohnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
First Hospital of China Medical UniversityThe People's Hospital of Liaoning ProvinceCompletedCoronary Artery DiseaseChina
-
CooperVision International Limited (CVIL)Completed
-
Children's Hospital of PhiladelphiaThe Hilda & Preston Davis FoundationCompleted
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicCompleted
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonNot yet recruiting